Placentrex Injection 0.1 gm Albert David Limited
| Features | |
| Active substance | Placenta Extract |
| Also known as | Placental biostimulation therapy |
| Blood pressure | Unlikely to have a direct effect |
| Chemical name | Human Placental Extract |
| Dosage (medical) | Typically, 2 mL intramuscular injection 2-3 times per week or as per medical advice |
| Dosage (sports) | Not conventionally used in sports settings |
| Effects | Promotes tissue repair, enhances skin rejuvenation, anti-inflammatory properties |
| Formula | Not applicable (complex mixture of bioactive molecules) |
| Half-life | Variable, depending on components |
| Hepatotoxicity | Low, but depends on source and processing |
| Lab Test | Specific tests not defined due to variable composition |
| Main action | Tissue regeneration, immune modulation |
| Side effects | Possibility of infection, allergic reactions, transmission of disease if not properly screened |
| Storage conditions | Generally requires refrigeration (2-8В°C) |
| Strength | 0.1gm |
| Substance class | Biological extract |
| Trade name | Laennec, Melsmon, Curacen |
| Use in sports | Not typically used due to lack of clear performance-enhancing benefits and potential ethical/legal issues |
| Water Retention | Minimal to none |
| Manufacturer | Albert David Limited |
| Packing | 7 vial/cartridge |